Dr Gabriella Gobbi
Current affiliation: McGill University
Subject: Medicine And Medical Sciences
Primary location: Canada
Effects of quetiapine and olanzapine in patients with psychosis and violent behavior: a pilot randomized, open-label, comparative study
Published in:Neuropsychiatric Disease and Treatment
Publication date:2014-05-01
Quetiapine in Postpartum Psychosis
Published in:Journal of Clinical Psychopharmacology
Publication date:2014-12-01
Modulation of Serotonin Firing Activity Through CB1 Agonists and FAAH Inhibitors
Published in:Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders
Publication date:2013-01-01
M-B-035 SLEEP IN MT2 MELATONIN RECEPTOR KNOCKOUT MICE
Published in:Sleep Medicine
Publication date:2011-09-01
The Psychopharmacology of Aggressive Behavior
Published in:Journal of Clinical Psychopharmacology
Publication date:2012-02-01A Translational Approach
Clonidine fails to modify dopaminergic neuronal activity during morphine withdrawal
Published in:Psychopharmacology
Publication date:2001-10-01
Effect of neurokinin-1 receptor antagonists on serotoninergic, noradrenergic and hippocampal neurons: Comparison with antidepressant drugs
Published in:Peptides
Publication date:2005-08-01
Characterization of serotonin neurotransmission in knockout mice: implications for major depression
Published in:Reviews in the Neurosciences
Publication date:2012-01-01
Sodium- and magnesium-valproate in vivo modulate glutamatergic and GABAergic synapses in the medial prefrontal cortex
Published in:Psychopharmacology
Publication date:2006-02-22
Serotonin Firing Activity as a Marker for Mood Disorders: Lessons from Knockout Mice
Published in:International Review of Neurobiology
Publication date:2005-01-01
Efficacy of Topiramate, Valproate, and Their Combination on Aggression/Agitation Behavior in Patients With Psychosis
Published in:Journal of Clinical Psychopharmacology
Publication date:2006-10-01
Neurochemical and Psychotropic Effects of Bupropion in Healthy Male Subjects
Published in:Journal of Clinical Psychopharmacology
Publication date:2003-06-01
Sleep–wake characterization of double MT1/MT2 receptor knockout mice and comparison with MT1 and MT2 receptor knockout mice
Published in:Behavioural Brain Research
Publication date:2013-04-01
Melatonin, selective and non-selective MT1/MT2 receptors agonists: Differential effects on the 24-h vigilance states
Published in:Neuroscience Letters
Publication date:2014-02-01
Role of the Endocannabinoid System in Etiopathology of Major Depression
Published in:Neurobiology of Depression
Publication date:2011-09-09
Endocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models
Published in:Current Pharmaceutical Design
Publication date:2009-05-01
Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress
Published in:European Neuropsychopharmacology
Publication date:2009-03-01
Brain TRPV1: a depressing TR(i)P down memory lane?
Published in:Trends in Pharmacological Sciences
Publication date:2008-12-01
Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission
Published in:Neurobiology of Disease
Publication date:2010-03-01
Clozapine blocks dopamine, 5-HT2 and 5-HT3 responses in the medial prefrontal cortex: an in vivo microiontophoretic study
Published in:European Neuropsychopharmacology
Publication date:1999-12-01
The Psychopharmacology of Aggressive Behavior
Published in:Journal of Clinical Psychopharmacology
Publication date:2012-04-01A Translational Approach
The cannabinoid CB1receptor and the endocannabinoid anandamide: possible antidepressant targets
Published in:Expert Opinion on Therapeutic Targets
Publication date:2008-10-14
Chronic nandrolone decanoate exposure during adolescence affects emotional behavior and monoaminergic neurotransmission in adulthood
Published in:Neuropharmacology
Publication date:2014-08-01
Potentiation of excitatory serotonergic responses by MK-801 in the medial prefrontal cortex
Published in:Naunyn-Schmiedeberg s Archives of Pharmacology
Publication date:2009-09-02
Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology
Published in:Journal of Psychiatry and Neuroscience
Publication date:2014-01-01
N -(Substituted-anilinoethyl)amides: Design, Synthesis, and Pharmacological Characterization of a New Class of Melatonin Receptor Ligands
Published in:Journal of Medicinal Chemistry
Publication date:2007-12-01
N-(Anilinoethyl)amides: Design and Synthesis of Metabolically Stable, Selective Melatonin Receptor Ligands
Published in:ChemMedChem
Publication date:2009-10-05
An index of 5-HT synthesis changes during early antidepressant treatment: α-[11C]methyl-l-tryptophan PET study
Published in:Neurochemistry International
Publication date:2008-03-01
Electrophysiological characterization of dopamine neuronal activity in the ventral tegmental area across the light-dark cycle
Published in:Synapse
Publication date:2014-07-04Dopamine Neurotransmission Across the Light-Dark Cycle
Mirtazapine and paroxetine in major depression: A comparison of monotherapy versus their combination from treatment initiation
Published in:European Neuropsychopharmacology
Publication date:2009-07-01
Alterations of the thalamo-cortical system in rats prenatally exposed to ethanol are prevented by concurrent administration of acetyl- l-carnitine
Published in:Brain Research
Publication date:1995-11-01
The Therapeutic Potential of the Endocannabinoid System for the Development of a Novel Class of Antidepressants
Published in:Trends in Pharmacological Sciences
Publication date:2009-09-01
Monoaminergic Changes in Locus Coeruleus and Dorsal Raphe Nucleus Following Noradrenaline Depletion
Published in:Neurochemical Research
Publication date:2009-02-20
Anxiolytic effects of the melatonin MT2 receptor partial agonist UCM765: Comparison with melatonin and diazepam
Published in:Progress in Neuro-Psychopharmacology and Biological Psychiatry
Publication date:2012-12-01
Genetic Deletion of Fatty Acid Amide Hydrolase Alters Emotional Behavior and Serotonergic Transmission in the Dorsal Raphe, Prefrontal Cortex, and ...
Published in:Neuropsychopharmacology
Publication date:2010-06-23
Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype
Published in:Nature Neuroscience
Publication date:2006-08-13
Adolescent amphetamine exposure elicits dose-specific effects on monoaminergic neurotransmission and behaviour in adulthood
Published in:The International Journal of Neuropsychopharmacology
Publication date:2011-11-03
Effect of delta-9-tetrahydrocannabinol on behavioral despair and on pre- and postsynaptic serotonergic transmission
Published in:Progress in Neuro-Psychopharmacology and Biological Psychiatry
Publication date:2012-07-01
Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway
Published in:European Neuropsychopharmacology
Publication date:2012-09-01
Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice
Published in:Psychopharmacology
Publication date:2010-11-02
Unusually mild tuberous sclerosis phenotype is associated withTSC2R905Q mutation
Published in:Annals of Neurology
Publication date:2006-11-01
Spadin, a Sortilin-Derived Peptide, Targeting Rodent TREK-1 Channels: A New Concept in the Antidepressant Drug Design
Published in:PLoS Biology
Publication date:2010-04-13
Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways
Published in:Pain
Publication date:2015-02-01
Anatomical and cellular localization of melatonin MT1and MT2receptors in the adult rat brain
Published in:Journal of Pineal Research
Publication date:2015-03-23
MT2 Melatonin Receptors: Their Role in Sleep and Neuropsychiatric Disorders
Published in:Melatonin
Publication date:2014-09-04
Melatonin
Published in:Not available
Publication date:2014-09-30Therapeutic Value and Neuroprotection
Translational Research in Suicide: Is It Possible to Study Suicide in Animal Models?
Published in:Understanding Suicide
Publication date:2016-01-01
MELATONIN: “Therapeutic Value and Neuroprotection” edited by Venkatramanujan Srinivasan, Gabriella Gobbi, Samuel D. Shillcutt and Sibel Suzen
Published in:Journal of Experimental and Clinical Medicine
Publication date:2014-09-13
The Y2 receptor antagonist BIIE0246 reverses corticosterone-induced anxiogenic-related behavior and neuronal hypertrophy
Published in:Neuropeptides
Publication date:2016-02-01
The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in th...
Published in:European Neuropsychopharmacology
Publication date:2016-03-01
Valproate augmentation in a subgroup of patients with treatment-resistant unipolar depression
Published in:The World Journal of Biological Psychiatry
Publication date:2015-10-07
Tryptophan via serotonin/kynurenine pathways abnormalities in a large cohort of aggressive inmates: markers for aggression
Published in:Progress in Neuro-Psychopharmacology and Biological Psychiatry
Publication date:2016-10-01
The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors
Published in:Pharmacological Research
Publication date:2016-11-01
Antinociceptive properties of selective MT2 melatonin receptor partial agonists
Published in:European Journal of Pharmacology
Publication date:2015-10-01